Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweight.

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Svane MS, Johannesen HH, Hansen AE, Martinussen C, Bojsen-Møller KN, Hansen ML, Deacon CF, Keller SH, Klausen TL, Loft A, Kjaer A, Löfgren J, Madsbad S, Holst JJ, Wewer Albrechtsen NJ.

Journal title: Int J Obes

Journal publisher: Nature Publishing Group

Published year: 2022

DOI identifier: 10.1038/s41366-022-01207-y

ISSN: 0307-0565